State Street’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Sell |
64,564
-28,833
| -31% | -$1.36M | ﹤0.01% | 3157 |
|
|
2025
Q1 | $3.65M | Buy |
93,397
+1,852
| +2% | +$72.4K | ﹤0.01% | 3005 |
|
|
2024
Q4 | $4.96M | Buy |
91,545
+3,908
| +4% | +$212K | ﹤0.01% | 2985 |
|
|
2024
Q3 | $4.42M | Buy |
87,637
+42,980
| +96% | +$2.17M | ﹤0.01% | 3023 |
|
|
2024
Q2 | $1.96M | Sell |
44,657
-704
| -2% | -$31K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $2.28M | Buy |
45,361
+15,020
| +50% | +$754K | ﹤0.01% | 3237 |
|
|
2023
Q4 | $1.83M | Buy |
30,341
+9,541
| +46% | +$576K | ﹤0.01% | 3340 |
|
|
2023
Q3 | $1.19M | Buy |
+20,800
| New | +$1.19M | ﹤0.01% | 3486 |
|